Zika therapeutic targets identified using CRISPR technology
University of Massachusetts Medical School researchers, led by Kerafast providing investigator Dr. Abraham L. Brass, have used CRISPR technology to identify human proteins required for Zika virus infection and replication. These proteins now represent potential targets for the development of Zika treatments. Zika is a flavivirus, a family of mosquito-trasmitted viruses that also includes dengue,